Financhill
Back

Catalyst Pharmaceuticals Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.

Catalyst Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 22.3 Buy
20-day SMA: 23.52 Sell
50-day SMA: 22.72 Sell
200-day SMA: 20.88 Buy
8-day EMA: 22.47 Buy
20-day EMA: 20.16 Buy
50-day EMA: 13.23 Buy
200-day EMA: 4.44 Buy

Catalyst Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.56 Buy
Relative Strength Index (14 RSI): 48.15 Sell
Chaikin Money Flow: 301929 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.88 - 24.6) Sell
Bollinger Bands (100): (21.21 - 23.43) Buy

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Catalyst Pharmaceuticals Stock

Is Catalyst Pharmaceuticals Stock a Buy?

CPRX Technical Analysis vs Fundamental Analysis

Buy
64
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy or a Sell?

Catalyst Pharmaceuticals Stock Info

Market Cap:
2.7B
Price in USD:
22.52
Share Volume:
720.9K

Catalyst Pharmaceuticals 52-Week Range

52-Week High:
26.16
52-Week Low:
14.47
Buy
64
Catalyst Pharmaceuticals (CPRX) is a Buy

Catalyst Pharmaceuticals Share Price Forecast

Is Catalyst Pharmaceuticals Stock a Buy?

Fundamental Analysis of Catalyst Pharmaceuticals

Is Catalyst Pharmaceuticals a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.11 per share, and an increase next year of $0.24 per share.

Technical Analysis of Catalyst Pharmaceuticals

Should I short Catalyst Pharmaceuticals stock?

* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.